7.67 USD
-0.01 (-0.13%)
7.4103 USD
-0.26 (-3.39%)
ChartMill assigns a Buy % Consensus number of 85% to KYTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 219.17% above the current price.
KYTX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KYTX.
In the previous month the buy percentage consensus was at a similar level.
KYTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | William Blair | Initiate | Outperform |
| 2025-05-27 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-04-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-11-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-10 | UBS | Initiate | Buy |
| 2024-09-19 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-07-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-07-03 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-03-04 | JP Morgan | Initiate | Overweight |
| 2024-03-04 | Morgan Stanley | Initiate | Overweight |
KYVERNA THERAPEUTICS INC / KYTX FAQ
What is the price target for KYTX stock?
12 analysts have analysed KYTX and the average price target is 24.48 USD. This implies a price increase of 219.17% is expected in the next year compared to the current price of 7.67.
How do analysts rate KYVERNA THERAPEUTICS INC (KYTX)?
The consensus rating for KYVERNA THERAPEUTICS INC (KYTX) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover KYVERNA THERAPEUTICS INC (KYTX) stock?
The number of analysts covering KYVERNA THERAPEUTICS INC (KYTX) is 12.